The ISoP Bengt-Erik Wiholm Memorial Lecture I. Ralph Edwards Commentary 03 January 2013 Pages: 181 - 185
Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes John DormandyMondira Bhattacharyaon behalf of the PROactive investigators Review Article 03 January 2013 Pages: 187 - 202
Reducing Harm Associated with Anticoagulation Marcie J. HurstingJoseph Soffer Review Article 03 January 2013 Pages: 203 - 218
Bisphosphonates and Atrial Fibrillation Yoon Kong LokeVinodh JeevananthamSonal Singh Original Research Article 03 January 2013 Pages: 219 - 228
Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK Carole FoggRachna KasliwalSaad A.W. Shakir Original Research Article 03 January 2013 Pages: 229 - 237
First-Trimester Itraconazole Exposure and Pregnancy Outcome Marco De SantisElena Di GianantonioMaurizio Clementi Original Research Article 03 January 2013 Pages: 239 - 244
Drug Safety Information Through the Internet Giovanni PolimeniAlessandra RussoAchille P. Caputi Original Research Article 03 January 2013 Pages: 245 - 253
Spontaneous ADR Reports as a Trigger for Pharmacogenetic Research Eugène van PuijenbroekJean ConemansKees van Grootheest Original Research Article 03 January 2013 Pages: 255 - 264